Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.23.2
Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2021 $ 282,217 $ 53,064,616 $ (57,515,129) $ 189,255 $ (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Common stock issued for accounts payable $ 90 2,084 2,174
Common stock issued for accounts payable (in Shares) 90,859        
Common stock issued for compensation $ 500 13,750 14,250
Common stock issued for compensation (in Shares) 500,000        
Common stock issued for conversion of Series C preferred stock $ 1,543 10,457 12,000
Common stock issued for conversion of Series C preferred stock (in Shares) 1,543,151        
Common stock issued in connection with debt $ 824 12,139 12,963
Common stock issued in connection with debt (in Shares) 823,529        
Preferred stock dividends and deemed dividend (14,005) (14,005)
Accretion of stock-based compensation 42,702 42,702
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 957,556 957,556
Net income (loss) (1,906,399) (13,020) (1,919,419)
Balance at Mar. 31, 2022 $ 285,174 54,103,304 (59,435,533) 176,235 (4,870,820)
Balance (in Shares) at Mar. 31, 2022 285,174,171        
Balance at Dec. 31, 2021 $ 282,217 53,064,616 (57,515,129) 189,255 (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632        
Net income (loss)         (2,928,771)
Balance at Jun. 30, 2022 $ 307,109 54,963,116 (60,452,441) 166,169 (5,016,047)
Balance (in Shares) at Jun. 30, 2022 307,108,719        
Balance at Mar. 31, 2022 $ 285,174 54,103,304 (59,435,533) 176,235 (4,870,820)
Balance (in Shares) at Mar. 31, 2022 285,174,171        
Common stock issued for professional fees $ 7,000 95,000 102,000
Common stock issued for professional fees (in Shares) 7,000,000        
Common stock issued for conversion of Series C preferred stock $ 13,185 88,815 102,000
Common stock issued for conversion of Series C preferred stock (in Shares) 13,184,548        
Common stock issued in connection with debt $ 1,750 30,986 32,736
Common stock issued in connection with debt (in Shares) 1,750,000        
Preferred stock dividends and deemed dividend 3,702 (17,622) (13,920)
Accretion of stock-based compensation 6,618 6,618
Relative fair value of warrants issued in connection with debt 325,785 325,785
Beneficial conversion feature on convertible debt 469,899 469,899
Beneficial conversion feature buyback related to debt extinguishment (160,993) (160,993)
Net income (loss) (999,286) (10,066) (1,009,352)
Balance at Jun. 30, 2022 $ 307,109 54,963,116 (60,452,441) 166,169 (5,016,047)
Balance (in Shares) at Jun. 30, 2022 307,108,719        
Balance at Dec. 31, 2022 $ 350,270 55,141,503 (62,693,184) 150,742 (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Common stock issued for cash and accrued compensation $ 54,545 245,455 300,000
Common stock issued for cash and accrued compensation (in Shares) 54,545,455        
Common stock issued for professional fees $ 6,667 33,333 40,000
Common stock issued for professional fees (in Shares) 6,666,667        
Common stock issued for accrued compensation $ 9,636 43,364 53,000
Common stock issued for accrued compensation (in Shares) 9,636,364        
Common stock issued for conversion of Series C preferred stock $ 26,586 74,814 101,400
Common stock issued for conversion of Series C preferred stock (in Shares) 26,585,614        
Preferred stock dividends and deemed dividend (13,687) (13,687)
Accretion of stock-based compensation 12,137 12,137
Net income (loss) (706,365) (16,722) (723,087)
Balance at Mar. 31, 2023 $ 447,704 55,550,606 (63,413,236) 134,020 (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272        
Balance at Dec. 31, 2022 $ 350,270 55,141,503 (62,693,184) 150,742 (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Net income (loss)         3,051,186
Balance at Jun. 30, 2023 $ 523,234 55,827,561 (59,633,941) 115,380 (3,167,766)
Balance (in Shares) at Jun. 30, 2023 523,233,675        
Balance at Mar. 31, 2023 $ 447,704 55,550,606 (63,413,236) 134,020 (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272        
Common stock issued for professional fees $ 6,500 32,950 39,450
Common stock issued for professional fees (in Shares) 6,500,000        
Common stock issued for compensation $ 2,500 23,500 26,000
Common stock issued for compensation (in Shares) 2,500,000        
Common stock issued for conversion of Series C preferred stock $ 23,158 59,442 82,600
Common stock issued for conversion of Series C preferred stock (in Shares) 23,157,922        
Common stock issued for conversion of debt, accrued interest and fees $ 43,372 157,017 200,389
Common stock issued for conversion of debt, accrued interest and fees (in Shares) 43,371,481        
Preferred stock dividends and deemed dividend (13,618) (13,618)
Accretion of stock-based compensation 4,046 4,046
Net income (loss) 3,792,913 (18,640) 3,774,273
Balance at Jun. 30, 2023 $ 523,234 $ 55,827,561 $ (59,633,941) $ 115,380 $ (3,167,766)
Balance (in Shares) at Jun. 30, 2023 523,233,675